Nvidia · NVIDIA Blog
Alzheimer’s disease is one of today’s leading global health challenges
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
★ Tier-1 Source
The bottlenecks are not enough high impact scientific findings, too much data living in institutional silos and too slow a pace of synthesis to keep up with the research that is published.
Key facts
- The Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN), working with NVIDIA, is using AI to change
- C-BRAIN currently runs 64 NVIDIA data center GPUs on premises alongside cloud-based nodes on Microsoft Azure, with additional NVIDIA GPU capacity, including NVIDIA Blackwell systems, on the horizon
- Researchers at C-BRAIN have already built two tools: OpenScientist, built with Lawrence Berkeley National Laboratory in an effort led by research scientist Justin Reese, and InsightEngine, built
- In published case studies, OpenScientist completed analyses in minutes that domain scientists estimated would take weeks to months, at a cost of under $10 per run
Summary
The Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN), working with NVIDIA, is using AI to change that. Alzheimer’s disease is one of today’s leading global health challenges, with over 10 million new dementia cases diagnosed each year. C-BRAIN, led by Dr. Randall Bateman and a consortium of 18 member institutions across academic, philanthropic, pharma and research organizations, launched in November 2025 to help scientists make better, faster discoveries by accelerating the research that makes new treatments possible.